Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
40.90
-0.70 (-1.68%)
Nov 17, 2026, 3:04 PM CST

Pharmaron Beijing Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
16,01314,09512,27611,53810,2667,444
Revenue Growth
18.23%14.82%6.39%12.39%37.92%45.00%
Gross Profit
5,3914,8904,1844,1163,7642,676
Operating Income
2,2442,0451,7191,6901,6671,448
Net Income
1,7701,6641,7931,6011,3751,661
Earnings Per Share
0.970.941.010.900.770.91
EPS Growth
13.69%-7.12%12.13%16.54%-15.21%38.94%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Chemical and Formulation Process Development and Manufacturing Services
1,222474.69407.52424.94351.03150.97
Clinical Research Services
2,1761,9571,8261,7371,394956.36
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services)
-8,1597,0476,660-4,566
CMC (Small Molecule CDMO) Service
-3,4832,9892,7112,4071,746
Others
-21.96.44.6126.1924.48
Total
16,00614,09512,27611,53810,2667,444

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
4,0342,6173,0626,6932,8566,178
Total Debt
7,4667,0405,9759,6986,1175,285
Net Cash (Debt)
-3,433-4,423-2,913-3,005-3,260893.04
Net Cash Growth
------68.12%
Net Cash Per Share
-1.89-2.50-1.64-1.69-1.840.49

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
2,6923,2212,5772,7542,1432,058
Capital Expenditures
-2,975-2,669-2,041-2,865-2,950-2,093
Free Cash Flow
-282.94551.97536.02-111.78-807.04-34.78
Free Cash Flow Growth
-2.98%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
33.66%34.70%34.09%35.67%36.67%35.95%
Operating Margin
14.02%14.51%14.01%14.64%16.23%19.45%
Pretax Margin
13.25%13.57%17.04%15.93%16.23%25.67%
Profit Margin
11.05%11.80%14.61%13.88%13.39%22.31%
FCF Margin
-1.77%3.92%4.37%-0.97%-7.86%-0.47%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.2000.2000.2000.2000.2000.200
Dividend Per Share Growth
0%0%0%0%0%50.04%
Dividend Yield
0.49%0.75%0.84%0.76%0.46%0.34%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
42.0228.3423.3329.5955.9864.05
Forward PE
25.8424.7226.2225.7235.7559.23
P/FCF Ratio
-85.4478.07---
PS Ratio
4.373.353.414.117.5014.29